pharma · Neuromyelitis Optica Spectrum Disorders
Tianjin Huanhu Hospital
Tianjin Huanhu Hospital is a pharma organization headquartered in CN. Primary therapeutic focus areas include Neuromyelitis Optica Spectrum Disorders. NovaPharmaNews links 1 clinical program(s), 0 drug profile(s), and 0
CN HQ
NMPA registrant Type
Company details
- Status
- Public
- HQ
- CN
- Programs
- 1
- Drugs
- 0
- Patents
- 0
QT-019C
Phase 1 · small molecule · Neuromyelitis Optica Spectrum Disorders
QT-019C for Neuromyelitis Optica Spectrum Disorders is a Phase 1 program (small_molecule) at Tianjin Huanhu Hospital with 1 ClinicalTrials.gov record(s).
Internal code QH-HH-03
Full intelligence profile for this program is being prepared.
At a glance
- Sponsor
- Tianjin Huanhu Hospital
- Phase
- Phase 1
- Modality
- small_molecule
- Indication
- Neuromyelitis Optica Spectrum Disorders
- Status
- active
- Trials
- 1